This research focused on synthesizing a trisaccharide with potential biological effects, particularly in cancer treatment, utilizing non-glycosaminoglycan building blocks derived from readily available D-glucose and methyl-α-D-glucopyranoside. Employing well-established synthetic pathways and protecting groups enabled precise glycosidic bond formation, yielding the target molecule in several steps. Ongoing collaboration aims to evaluate the compound's cell growth inhibitory, cytotoxic, and anti-inflammatory properties, representing a promising avenue for cancer therapy.